Myeloma treatment cost in Italy typically includes essential diagnostic steps like a consultation with a hematologist, which runs from $100 to $300. Total expenses depend on the disease stage, specific therapy protocols, and the chosen clinic tier. Patients often save approximately 40-60% compared to the US for advanced hematological care. Top cities for this treatment include Milan, Rome, and Palermo.
Typical Myeloma Treatment Costs in Italy
Bookimed Expert Insight: Patients requiring high-volume surgical expertise or complex stem cell protocols should consider Milan. San Raffaele Hospital is a top choice, performing over 52,000 operations annually with Newsweek-recognized excellence. For advanced cases, Dr. Jacopo Peccatori offers significant value by leading one of Italy's largest transplant units. His department conducts 90 transplants per year, specializing in myeloma and acute leukemia.
| Italy | Turkey | Austria | |
| Plasmapheresis | from $2,200 | from $1,200 | from $2,000 |
| Therapeutic Apheresis | from $2,200 | from $1,350 | - |
| Plasma Exchange | from $2,250 | from $3,900 | - |
| DFPP Plasmapheresis | from $2,900 | from $1,850 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Myeloma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Myeloma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Myeloma treatment journey.
Head of Bone Marrow Transplant Department at San Raffaele Scientific Institute – one of Italy's largest centers with 90 transplants annually.
Professor Fabio Ciceri, a leading expert in hematology, heads the Bone Marrow Transplantation Unit at San Raffaele Research Hospital. Principal investigator for cutting-edge clinical trials in hematological cancers.